Yarn Made from Human Tissue Helps Repair Wounds
By HospiMedica International staff writers Posted on 27 Feb 2020 |
Image: A spool of yarn made from extracellular matrix sheets (Photo courtesy of Nicolas L`Heureux/ INSERM)
Yarn grown from human skin cells can be knitted, crocheted, and sewed to create pouches, valves, and tubes, and even perforated membranes, according to a new study.
Developed by researchers at the French National Institute of Health and Medical Research (INSERM; Bordeaux, France), Fountain Therapeutics (Culver City, CA, USA), and other institutions, the “human textile” is made of cell-assembled extracellular matrix (CAM) sheets extracted from cultured adult, human fibroblasts. The biological, yet robust, material can be spun into a mass-produced yarn with a range of physical and mechanical properties for use in a range of clinical applications.
In the study, the researchers showed that the material can be used as a simple suture to close a wound, or even nitted into fully biological, human, implantable tissue-engineered vascular grafts (TEVGs) with mechanical burst pressure, suture retention strength, and transmural permeability that surpass clinical requirements. The yarn was also used to stitch up a rat’s wound, with the wound healing fully over the course of two weeks. IN addition, the researchers created a skin graft, using a custom-designed loom, to successfully stop a sheep’s artery from leaking. The study was published on January 26, 2020, in Acta Biomaterialia.
“By combining this truly ‘bio’ material with a textile-based assembly, this original tissue engineering approach is highly versatile and can produce a variety of strong human textiles that can be readily integrated in the body,” concluded senior author Nicolas L'Heureux, PhD, of INSERM, and colleagues. “This novel strategy holds the promise of a next generation of medical textiles that will be mechanically strong without any foreign scaffolding, and will have the ability to truly integrate into the host's body.”
The ECM is a collection of extracellular molecules that provides structural and biochemical support to the surrounding cells. It includes the interstitial matrix, composed of polysaccharide gels and fibrous proteins, and the basement membrane, which are sheet-like depositions on which various epithelial cells rest. Each type of connective tissue in animals has a different ECM; collagen fibers and bone mineral comprise the ECM of bone tissue; reticular fibers and ground substance comprise the ECM of loose connective tissue; and blood plasma is the ECM of blood.
Related Links:
French National Institute of Health and Medical Research
Fountain Therapeutics
Developed by researchers at the French National Institute of Health and Medical Research (INSERM; Bordeaux, France), Fountain Therapeutics (Culver City, CA, USA), and other institutions, the “human textile” is made of cell-assembled extracellular matrix (CAM) sheets extracted from cultured adult, human fibroblasts. The biological, yet robust, material can be spun into a mass-produced yarn with a range of physical and mechanical properties for use in a range of clinical applications.
In the study, the researchers showed that the material can be used as a simple suture to close a wound, or even nitted into fully biological, human, implantable tissue-engineered vascular grafts (TEVGs) with mechanical burst pressure, suture retention strength, and transmural permeability that surpass clinical requirements. The yarn was also used to stitch up a rat’s wound, with the wound healing fully over the course of two weeks. IN addition, the researchers created a skin graft, using a custom-designed loom, to successfully stop a sheep’s artery from leaking. The study was published on January 26, 2020, in Acta Biomaterialia.
“By combining this truly ‘bio’ material with a textile-based assembly, this original tissue engineering approach is highly versatile and can produce a variety of strong human textiles that can be readily integrated in the body,” concluded senior author Nicolas L'Heureux, PhD, of INSERM, and colleagues. “This novel strategy holds the promise of a next generation of medical textiles that will be mechanically strong without any foreign scaffolding, and will have the ability to truly integrate into the host's body.”
The ECM is a collection of extracellular molecules that provides structural and biochemical support to the surrounding cells. It includes the interstitial matrix, composed of polysaccharide gels and fibrous proteins, and the basement membrane, which are sheet-like depositions on which various epithelial cells rest. Each type of connective tissue in animals has a different ECM; collagen fibers and bone mineral comprise the ECM of bone tissue; reticular fibers and ground substance comprise the ECM of loose connective tissue; and blood plasma is the ECM of blood.
Related Links:
French National Institute of Health and Medical Research
Fountain Therapeutics
Latest Surgical Techniques News
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
- Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
- Computational Models Predict Heart Valve Leakage in Children
- Breakthrough Device Enables Clear and Real-Time Visual Guidance for Effective Cardiovascular Interventions
- World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis
- World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient
- Robotically Assisted Lung Transplants Could Soon Become a Reality
- AI to Provide Heart Transplant Surgeons with New Decision-Making Data
- New Surgical Tool Empowers Precision and Confidence in Operating Room